Effect of occlusal splint on oxidative stress markers and psychological aspects of chronic temporomandibular pain: a randomized controlled trial

Iva Z Alajbeg, Ema Vrbanović, Ivana Lapić, Ivan Alajbeg, Lea Vuletić, Iva Z Alajbeg, Ema Vrbanović, Ivana Lapić, Ivan Alajbeg, Lea Vuletić

Abstract

Temporomandibular disorders (TMD), when progress to a chronic state, might contribute to psychosocial or psychological distress. This study aimed to evaluate the effect of stabilization splint (SS) therapy on pain, pain-related disability and psychological traits of chronic TMD patients, as well as to assess selected oxidative stress (OS) biomarkers during 6-month treatment and associate them with the symptoms of anxiety and depression. Thirty-four participants were randomly assigned into two treatment groups [SS and placebo splint (PS)]. Primary outcomes were pain intensity and pain-related disability while secondary outcomes included depressive and anxiety symptoms. The influence of the treatment type was analyzed with regards to the levels of OS biomarkers in saliva. Participants treated with SS demonstrated significantly greater improvement in pain-related disability (Pain-free mouth opening: p = 0.018, η2 = 0.166; Number of disability days: p = 0.023, η2 = 0.155) and greater reduction of depressive symptoms scores (p = 0.007, η2 = 0.207). When compared to the PS group, participants in the SS group showed a significant reduction of oxidant/antioxidant ratio (p = 0.018, η2 = 0.167) at a 3-month follow-up. A stabilization splint provides advantages over PS in the treatment of depressive symptoms and pain-related disability. Furthermore, clinical success in terms of reduction of depressive symptoms, which correlates with the reduction of oxidative stress markers in the SS group, indicates that oxidative stress is related to psychological factors in chronic TMD patients.

Conflict of interest statement

The authors declare that they have no potential conflicts of interest.

Figures

Figure 1
Figure 1
Distribution of the participants throughout the study.
Figure 2
Figure 2
Relative changes of primary outcomes in two treatment groups. The whiskers represent standard errors; the asterisk indicates a statistical significant difference (p SS stabilization splint, PS placebo splint.
Figure 3
Figure 3
Relative changes of secondary outcomes in two treatment groups. GAD 7 generalized anxiety, PHQ-9 depression; the whiskers represent standard errors; the asterisk indicates a statistical significant difference (p < 0.05); SS stabilization splint, PS placebo splint.
Figure 4
Figure 4
Relative changes of total antioxidant capacity in two treatment groups. TAC: total antioxidant capacity; the whiskers represent standard errors; the asterisk indicates a statistical significant difference (p 

References

    1. Chisnoiu AM, Pico AM, Popa S, Chisnoiu PD, Lascu L, Picos A, Chisnoiu R. Factors involved in the etiology of temporomandibular disorders—a literature review. Clujul Med. 2015;88:473–478.
    1. Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015;91:378–386.
    1. Ohrbach R, Dworkin SF. Five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables. Pain. 1998;74:315–326. doi: 10.1016/S0304-3959(97)00194-2.
    1. Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom. Med. 2002;64:773–786.
    1. Tan G, Jensen MP, Thornby J, Sloan PA. Negative emotions, pain, and functioning. Psychol Serv. 2008;5:26–35. doi: 10.1037/1541-1559.5.1.26.
    1. Carlson CR, Okeson JP, Falace DA, Nitz AJ, Curran SL, Anderson D. Comparison of psychologic and physiologic functioning between patients with masticatory muscle pain and matched controls. J Orofacial Pain. 1993;7:15–22.
    1. Fillingim RB, et al. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case–control study. J. Pain. 2011;12:T46–T60. doi: 10.1016/j.jpain.2011.08.007.
    1. Macfarlane TV, Gray RJM, Kincey J, Worthington HV. Factors associated with the temporomandibular disorder, pain dysfunction syndrome (PDS): Manchester case–control study. Oral Dis. 2001;7:321–330. doi: 10.1034/j.1601-0825.2001.00758.x.
    1. Manfredini D, Winocur E, Ahlberg J, Guarda-Nardini L, Lobbezoo F. Psychosocial impairment in temporomandibular disorders patients. RDC/TMD axis II findings from a multicenter study. J Dent. 2010;38:765–772. doi: 10.1016/j.jdent.2010.06.007.
    1. Quartana PJ, Buenaver LF, Edwards RR, Klick B, Haythornthwaite JA, Smith MT. Pain catastrophizing and salivary cortisol responses to laboratory pain testing in temporomandibular disorder and healthy participants. J. Pain. 2010;11:186–194. doi: 10.1016/j.jpain.2009.07.008.
    1. Burris JL, Cyders MA, De LR, Smith GT, Carlson CR. Posttraumatic stress disorder symptoms and chronic orofacial pain: an empirical examination of the mutual maintenance model. J. Orofac. Pain. 2009;23:243–252.
    1. Vasudeva S, Iyengar A, Seetaramaiah N. Correlation of anxiety levels between temporomandibular disorder patients and normal subjects. J. Oral Dis. 2014;579674:5.
    1. Fillingim RB, et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain. 2013;14:T75–90. doi: 10.1016/j.jpain.2013.06.009.
    1. Epker J, Gatchel RJ. Coping profile differences in the biopsychosocial functioning of patients with temporomandibular disorder. Psychosom. Med. 2000;62:69–75. doi: 10.1097/00006842-200001000-00010.
    1. Garofalo JP, Gatchel RJ, Wesley AL, Ellis E. Predicting chronicity in acute temporomandibular joint disorders using the research diagnostic criteria. J. Am. Dent. Assoc. 1998;129:438–447. doi: 10.14219/jada.archive.1998.0242.
    1. Themessl-Huber M. Weak evidence supports the use of psychosocial interventions for chronic orofacial pain. Evid. Based Dent. 2012;132:58. doi: 10.1038/sj.ebd.6400865.
    1. Costa YM, Porporatti AL, Stuginski-Barbosa J, Bonjardim LR, Conti PC. Additional effect of occlusal splints on the improvement of psychological aspects in temporomandibular disorder subjects: a randomized controlled trial. Arch Oral Biol. 2015;60:738–744. doi: 10.1016/j.archoralbio.2015.02.005.
    1. Fricton J, et al. Systematic review and meta-analysis of randomized controlled trials evaluating intraoral orthopedic appliances for temporomandibular disorders. J. Orofac Pain. 2010;24:237–254.
    1. Basi DL, et al. Human temporomandibular joint and myofascial pain biochemical profiles: a case–control study. J. Oral Rehabil. 2012;39:326–337. doi: 10.1111/j.1365-2842.2011.02271.x.
    1. Rodríguez Sotillo D, Velly AM, Hadley M, Fricton JR. Evidence of oxidative stress in temporomandibular disorders: a pilot study. J. Oral Rehabil. 2011;38:722–728. doi: 10.1111/j.1365-2842.2011.02216.x.
    1. Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y. A meta-analysis of oxidative stress markers in depression. PLoS ONE. 2015;10:e0138904. doi: 10.1371/journal.pone.0138904.
    1. Fedoce ADG, Ferreira F, Bota RG, Bonet-Costa V, Sun PY, Davies KJA. The role of oxidative stress in anxiety disorder: cause or consequence? Free Radic Res. 2018;52:737–750. doi: 10.1080/10715762.2018.1475733.
    1. Liu Z, Ren Z, Zhang J, Chuang CC, Kandaswamy E, Zhou T, Zuo L. Role of ROS and nutritional antioxidants in human diseases. Front. Physiol. 2018;9:477. doi: 10.3389/fphys.2018.00477.
    1. Gray RJ, Davies SJ, Quayle AA. A clinical approach to temporomandibular disorders: a clinical approach to treatment. Br. Dent. J. 1994;177:171–178. doi: 10.1038/sj.bdj.4808543.
    1. Klasser GD, Greene CS. Oral appliances in the management of temporomandibular disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009;107:144–150. doi: 10.1016/j.tripleo.2008.10.007.
    1. Kamodyová N, Tóthová L, Celec P. Salivary markers of oxidative stress and antioxidant status: influence of external factors. Dis Markers. 2013;34:313–321. doi: 10.1155/2013/341302.
    1. Alajbeg IZ, et al. Within-subject reliability and between-subject variability of oxidative stress markers in saliva of healthy subjects: A longitudinal pilot study. Dis. Markers. 2013;2017(2697464):313–321.
    1. Schiffman E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for Clinical Research Applications: Recommendations of the International RDC/TMD Consortium Network and orofacial pain special interest Group. J.. Oral Facial Pain Headache. 2014;28:6–27. doi: 10.11607/jop.1151.
    1. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133–149. doi: 10.1016/0304-3959(92)90154-4.
    1. Michelotti A, Iodice G, Vollaro S, Steenks MH, Farella M. Evaluation of the short- term effectiveness of education versus an occlusal splint for the treatment of myofascial pain of the jaw muscles. J Am Dent Assoc. 2012;143:47–53. doi: 10.14219/jada.archive.2012.0018.
    1. Löw B, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46:266–274. doi: 10.1097/MLR.0b013e318160d093.
    1. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006;166:1092–1097. doi: 10.1001/archinte.166.10.1092.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Baş B, et al. Effect of occlusal splint on interleukin 6, malondialdehyde and 8-hydroxydeoxyguanosine levels in synovial fluid of patients with temporomandibular disorders. Int. J. Oral Maxillofac. Surg. 2019;S0901–5027:31114–31122.
    1. Dao TT, Lavigne GJ. Oral splints: the crutches for temporomandibular disorders and bruxism? Crit Rev Oral Biol Med. 1998;9:345–361. doi: 10.1177/10454411980090030701.
    1. Bäck K, Hakeberg M, Wide U, Hange D, Dahlström L. Orofacial pain and its relationship with oral health-related quality of life and psychological distress in middle-aged women. Acta Odontol Scand. 2020;78:74–80. doi: 10.1080/00016357.2019.1661512.
    1. Von Korff M, Simon G. The relationship between pain and depression. Br J Psychiatry Suppl. 1996;30:101–108. doi: 10.1192/S0007125000298474.
    1. Doron J, Trouillet R, Maneveau A, Ninot G, Neveu D. Coping profiles, perceived stress and health-related behaviors: A cluster analysis approach. Health Promot Int. 2015;30:88–100. doi: 10.1093/heapro/dau090.
    1. Vrbanović E, Lapić I, Rogić D, Alajbeg IZ. Changes in salivary oxidative status, salivary cortisol, and clinical symptoms in female patients with temporomandibular disorders during occlusal splint therapy: a 3-month follow up. BMC Oral Health. 2019;19:100. doi: 10.1186/s12903-019-0791-8.
    1. Vrbanović E, et al. Salivary oxidant/antioxidant status in chronic temporomandibular disorders is dependent on source and intensity of pain—a pilot study. Front Physiol. 2018;9:1405. doi: 10.3389/fphys.2018.01405.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever